Key terms
About VVOS
Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). Its solutions are also offered for patients with mild-to-moderate obstructive sleep apnea (OSA). The company was founded by Gurdev Dave Singh, Susan McCullough, RaeAnn Byrnes, Todd Huntsman, and R. Kirk Huntsman on July 7, 2016 and is headquartered in Littleton, CO.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest VVOS news
Mar 28
4:28pm ET
Vivos Therapeutics reports FY EPS ($11.14), two estimates ($10.51)
Mar 20
2:38pm ET
LivaNova jumps nearly 12% after saying trial likely to meet primary endpoint
Feb 23
7:04am ET
Vivos Therapeutics initiated with a Buy at Alliance Global Partners
Feb 15
9:14am ET
Vivos Therapeutics Secures $8M Through Strategic Equity Deals
Feb 15
8:05am ET
Vivos Therapeutics announces exercise of warrants for $4M in gross proceeds
Feb 06
7:38am ET
Vivos Therapeutics highlights favorable market developments
Jan 08
7:56am ET
Vivos Therapeutics seeing positive preliminary metrics following FDA clearance
No recent press releases are available for VVOS
VVOS Financials
Key terms
Ad Feedback
VVOS Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
VVOS Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
